Home LiteratureArticle Details
PMID: 479764 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex.

The Journal of experimental medicine ·Vol. 150 ·No. 3 ·1979-09-19 ·Pages 633-45

Polley MJ, Nachman RL

Abstract

Thrombin-mediated platelet aggregation and release is enhanced by the presence of C3, C5, C6, C7, C8, and C9 of human complement. The interaction of thrombin with its receptor on the platelet membrane initiates activation of complement on the platelet surface. Trypsin-mediated platelet function is not enhanced by the addition of complement, probably because trypsin has no receptor on the platelet surface so activation of complement is triggered in the fluid phase and not on the platelet surface. Activation of complement by thrombin led to production of dimers of the C5b-9 complex on the platelet surface. These complexes were eluted from the platelet membrane and were identified physicochemically and morphologically. The mechanism of complement-induced enhancement of platelet function is not clear, however, it probably is mediated via the arachidonic acid transormation pathway because this activity was blocked by known inhibitors of cyclo-oxygenase, namely, aspirin and indomethacin.

MeSH Terms
Antithrombin III/physiology Aspirin/pharmacology Blood Platelets/physiology Complement C5/metabolism Complement C9/metabolism Complement System Proteins/physiology Humans In Vitro Techniques Platelet Aggregation/drug effects Serotonin/metabolism Thrombin/pharmacology Trypsin/pharmacology
Chemicals
Complement C5 Complement C9 Serotonin Antithrombin III Complement System Proteins Trypsin Thrombin Aspirin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Polley M J
Nachman R L
References (21)
21 references, click to expand
  1. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    J Exp Med. 1965 Aug 1;122:277-98 PMID: 14316946
  2. ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.
    J Exp Med. 1963 Sep 1;118:447-66 PMID: 14078003
  3. Complement abnormalities in human disease.
    Hosp Pract. 1978 Dec;13(12):65-76 PMID: 153321
  4. Molecular nature of the complement lesion.
    Proc Natl Acad Sci U S A. 1978 Nov;75(11):5655-9 PMID: 281714
  5. C5b-9 dimer: isolation from complement lysed cells and ultrastructural identification with complement-dependent membrane lesions.
    J Exp Med. 1979 Feb 1;149(2):448-58 PMID: 762498
  6. The human complement system in thrombin-mediated platelet function.
    J Exp Med. 1978 Jun 1;147(6):1713-26 PMID: 681879
  7. The perturbation of thrombin binding to human platelets by trypsin and neuraminidase.
    Biochim Biophys Acta. 1977 Jun 23;498(1):21-8 PMID: 884149
  8. The ninth component of human complement: isolation, description and mode of action.
    Immunology. 1969 Jun;16(6):719-35 PMID: 4182367
  9. A method of trace iodination of proteins for immunologic studies.
    Int Arch Allergy Appl Immunol. 1966;29(2):185-9 PMID: 4160044
  10. Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis.
    Immunochemistry. 1972 Jul;9(7):709-23 PMID: 4261220
  11. The perturbation of thrombin binding to human platelets by anions.
    J Clin Invest. 1975 Oct;56(4):945-50 PMID: 1159095
  12. The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex.
    J Exp Med. 1975 Apr 1;141(4):724-35 PMID: 47885
  13. Iodination of the human platelet membrane. Studies of the major surface glycoprotein.
    J Biol Chem. 1973 Apr 25;248(8):2928-36 PMID: 4697403
  14. Platelet-dependent generation of chemotactic activity in serum.
    J Exp Med. 1973 Jun 1;137(6):1419-30 PMID: 4709268
  15. Effect of temperature and inhibitors on serotonin-14C release from human platelets.
    Am J Physiol. 1971 Jan;220(1):105-11 PMID: 4992252
  16. Human platelet-initiated formation and uptake of the C5-9 complex of human complement.
    J Clin Invest. 1976 Jan;57(1):203-11 PMID: 812888
  17. Ultrastructural lesions on the surface of platelets associated with either blood coagulation or with antibody-mediated immune injury.
    J Exp Med. 1975 Jun 1;141(6):1261-8 PMID: 805209
  18. Purification of the sixth and seventh component of human complement without loss of hemolytic activity.
    J Immunol. 1976 Feb;116(2):263-9 PMID: 1249415
  19. Subcellular platelet factor VIII antigen and von Willebrand factor.
    J Exp Med. 1975 May 1;141(5):1101-13 PMID: 1168691
  20. Human C3 and C5: subunit structure and modifications by trypsin and C42-C423.
    J Immunol. 1975 Feb;114(2 pt 2):815-22 PMID: 1112981
  21. Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.
    J Biol Chem. 1970 Jun;245(12):3059-65 PMID: 5432796
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1979-09-19
Pages
633-45
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2185636
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com